November 17, 2017
Doctors are trying an experimental treatment designed to edit a man's genes while they are still in his body, hoping to cure him of a formerly incurable disease.
Republican lawmakers are aiming to send a compromise tax reform measure to President Trump before the end of this year.
CMS under its proposed rule for Medicare Advantage and Part D plans is seeking public comment on how to apply at the pharmacy counter certain rebates and discounts that typically are negotiated behind the scenes, among other requests for comment.
November 16, 2017
Under the bill, CMS would maintain the 340B drug discount program's current hospital reimbursements instead of implementing $1.6 billion in cuts called for under a final rule the Trump administration released earlier this month.
Health care industry observers are questioning how President Trump's pick for HHS secretary, Alex Azar, will tackle rising prescription drug prices—a key focus of Trump's administration—given Azar's background as a pharmaceutical executive.
FDA Commissioner Scott Gottlieb warns against the use of unapproved products containing kratom—a plant-based substance that some say could be used as an alternative to opioid painkillers— saying the agency is aware of 36 deaths associated with using kratom and "has evidence to show that there are significant safety issues associated with its use," including liver damage, seizures, and withdrawal symptoms.
Communications between Amazon and state regulators in Tennessee and Indiana indicate Amazon did not acquire pharmacy licenses in those states to sell prescription drugs, but rather to sell medical devices and supplies.
November 15, 2017
The drug, Otsuka Pharmaceutical's Abilify MyCite, includes a sensor manufactured by Proteus Digital Health that sends information about the dosage amount and time of ingestion to a smartphone application that can be viewed by patients and shared with providers and caregivers.
While Kymriah, the first gene therapy for cancer approved for use in the United States, carries a $475,000 list price, treatment can grow even more expensive after accounting for potential side effects, experts say.
November 14, 2017
New guidelines from the American Heart Association and the American College of Cardiology lower the threshold for high blood pressure from 140/90 mm Hg to 130/80 mm Hg, marking the first change to the hypertension threshold in 14 years.
The Advisory Board Company. All Rights Reserved.